Thanks to those who joined us for our most recent virtual Key Opinion Leader (KOL) meeting on investigational compound, oral paltusotine for the treatment of acromegaly on August 8, 2023. The call showcases presentations about the current landscape and unmet medical need in acromegaly by KOLs Beverly MK Biller M.D. of Harvard Medical School and Karen JP Liebert, R.N., BSN of Massachusetts General Hospital.

The full archived session is now available for those who missed the opportunity to join or wish to revisit the conversation.